Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
Leveraging her previous research experience in pandemics and vaccination, Dr. Stockwell helps to make critical decisions about how RECOVER studies pediatric Long COVID.
De-identified data from thousands of adults with Long COVID are now available to researchers.
During the April 23rd, RECOVER Research Review (R3) Seminar, the speakers discussed our current knowledge of Long COVID in children, including epidemiology and risk factors, symptoms, underlying mechanisms that cause symptoms, and functional outcomes.
During the March 19th RECOVER Research Review (R3) Seminar, research presented findings about vaccine effectiveness against Long COVID in children and the association between SARS-CoV-2 infection and symptoms and conditions in children and adults.
RECOVER-AUTONOMIC will test at least three treatments for symptoms such as fast heart rate, dizziness and fatigue.
During the February 13th RECOVER Research Review (R3) Seminar, several pathobiology study awardees presented about the mechanisms of neurological (brain and nervous system) symptoms of Long COVID.
Gary Gibbons, M.D., Walter Koroshetz, M.D., and Jeanne Marrazzo, M.D., M.P.H. of the NIH answer questions about investing an additional $515 million in RECOVER's Long COVID research efforts.
This additional funding will build on and continue RECOVER's work to improve our understanding of and ability to diagnose, prevent, and treat Long COVID.
During the January 23rd RECOVER Research Review (R3) Seminar, researchers presented on the progress and future directions of the RECOVER Initiative. Speakers from the RECOVER adult, pediatric, and autopsy cohorts provided an overview of the progress to date, what is in the pipeline and the ultimate promise of RECOVER for each of the cohorts. A review of the current state of the science of Long COVID and gaps in knowledge was also discussed.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.